Dr. Beate Aurich is a pharmacovigilance/ drug safety physician, general paediatrician (MRCPCH London) and a methodological expert for paediatric pharmacovigilance in the 'conecting4children' (c4c) network. She has twenty years of pharmacovigilance and drug safety experience in pharmaceutical industry and academia. She is a member of ISOP, ISPE and ESDPPP and fellow of the governance, ethics, evidence, policy, practice (GE2P2) Global Foundation. Currently she is the head of Drug Safety Consulting S.A.S.U., an independent pharmacovigilance and drug safety consultancy for academic and industry sponsored paediatric and adult clinical research.

Francis P. Crawley is the Executive Director of the Good Clinical Practice Alliance – Europe (GCPA) and the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) in Brussels, Belgium. He is a philosopher specialised in ethical, legal, and regulatory issues in health research, having taught at several European, Asian, and Middle East universities. He is an expert in ethical review, data protection, and data sharing. He is a Data Protection Officer (DPO) on European Commission funded clinical research programmes. He currently chairs the methodologies sub-group of the Real Word Data Working Group at the Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians.

Dr. Granville provides insight, guidance, and a collaborative approach to build DIA’s thought leadership, research and content strategy to support innovation and building efficiency in drug, device and diagnostics development. She brings 2 decades of regulatory science-related research experience to her role at DIA. Her research career focused on developing data to support regulatory decision making in the fields of tobacco regulatory science, preclinical and molecular toxicology, nonclinical drug development, and public health. She holds a BS in Biology from Yale University, an MSPH in Environmental Health from UNC Chapel Hill and a PhD in Biochemistry and Molecular Genetics from George Washington University.

Dr. Kerpel-Fronius was born in Budapest, Hungary in 1940. He obtained medical diploma and board certificates in Clinical Laboratory Sciences and Clinical Pharmacology. He received PhD degree and DSc titles from the Hungarian Academy of Sciences. First, he worked in neurobiology at the Semmelweis University, later he led a clinical research group at the Hungarian National Institute of Oncology. Between 1989-2001 he worked in the international pharmaceutical industry. In 2001 he became Professor of Clinical Pharmacology at the Semmelweis University. In 2016 he was appointed Honorary Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He is member of the IFAPP Ethics Working Group.

Olena Popova is the Sr. Director, Clinical Operations and General Manager, IQVIA RDS Ukraine. From 1985 till 1992, she studied at National Medical University. From 1992 till 2000, she worked as a physician at endocrinology hospital. From 2000 till the present, she has been working for IQVIA RDS Ukraine holding CRA, Clinical Operation Manager, Site Management Head roles.

Anastasiia joined EURORDIS in May 2022 as Senior Project Manager where she takes responsibility for the operational components of the Ukraine response project and helps refine the organization’s priorities and activities in this area. Prior to EURORDIS, Anastasiia worked in humanitarian aid and international public law including leading two Council of Europe human rights projects in the Republic of Moldova. Prior, she worked in aid agencies, such as the International Committee of the Red Cross and Doctors Without Borders, supporting the organisations’ activities in Ukraine. She holds a Master of Laws degree from the Kyiv National Economic University and a Master’s degree in European Public Affairs and Policy from the College of Europe.